Literature DB >> 20869551

Vaginal birth after cesarean delivery: views from the private practitioner.

C Edward Wells1.   

Abstract

This survey was conducted to assess physician opinion regarding vaginal birth after cesarean delivery (VBAC) and to examine how physician and hospital characteristics influence the private obstetrical provider's decision to offer or not to offer trial of labor after cesarean delivery. A confidential postal survey of private practicing obstetricians in the Dallas-Ft. Worth Region (n = 774) of North Texas. Of 774 obstetrician-gynecologists, 458 completed and returned the survey for a response rate of 59%. The survey revealed that 52% of respondents offer VBAC to their patients and indicated that the most common reasons for declining use or discontinuation of VBAC were maternal-fetal safety concerns associated with uterine rupture followed by medico-legal liability concerns. Factors associated with physicians not providing VBAC for their patients were physicians in obstetrical practice <10 years, a physician's previous involvement in the care of women with uterine rupture complicated by maternal or neonatal complications, and a physician's previous involvement in cesarean delivery-related medical malpractice litigation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20869551     DOI: 10.1053/j.semperi.2010.05.008

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  11 in total

1.  The Association between Hospital Frequency of Labor after Cesarean and Outcomes in California.

Authors:  Mekhala V Dissanayake; Marit L Bovbjerg; Ellen L Tilden; Jonathan M Snowden
Journal:  Womens Health Issues       Date:  2020-08-25

2.  Toward an ethically responsible approach to vaginal birth after cesarean.

Authors:  Anne Drapkin Lyerly; Margaret Olivia Little
Journal:  Semin Perinatol       Date:  2010-10       Impact factor: 3.300

3.  Outcomes of trial of labor after cesarean birth by provider type in low-risk women.

Authors:  Matthew S Fore; Amanda A Allshouse; Nicole S Carlson; K Joseph Hurt
Journal:  Birth       Date:  2019-12-10       Impact factor: 3.689

4.  Hospital bans on trial of labor after cesarean and antepartum transfer of care.

Authors:  Melissa G Rosenstein; Laura Norrell; Anna Altshuler; William A Grobman; Anjali J Kaimal; Miriam Kuppermann
Journal:  Birth       Date:  2019-11-05       Impact factor: 3.081

5.  Trial of labour or elective repeat caesarean delivery:are women making an informed decision at Kenyatta national hospital?

Authors:  Phocas Biraboneye S; Omondi Ogutu; Jos van Roosmalen; Samson Wanjala; Kizito Lubano; John Kinuthia
Journal:  BMC Pregnancy Childbirth       Date:  2017-08-15       Impact factor: 3.007

6.  Validation of a predictive model for successful vaginal birth after cesarean section.

Authors:  Javier Enrique Fonseca; Juliana Lucía Rodriguez; Durley Maya Salazar
Journal:  Colomb Med (Cali)       Date:  2019-03-30

7.  Iranian midwives' attitudes and beliefs toward physiological childbirth: a cross-sectional study.

Authors:  Narges Sadeghzadeh; Leila Amiri-Farahani; Shima Haghani; Syedeh Batool Hasanpoor-Azghady
Journal:  BMC Pregnancy Childbirth       Date:  2019-10-12       Impact factor: 3.007

8.  A survey of access to trial of labor in California hospitals in 2012.

Authors:  Mary K Barger; Jennifer Templeton Dunn; Sage Bearman; Megan DeLain; Elena Gates
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-03       Impact factor: 3.007

9.  Trial of Labor After Two Prior Cesarean Deliveries: Patient and Hospital Characteristics and Birth Outcomes.

Authors:  Michael Dombrowski; Jessica L Illuzzi; Uma M Reddy; Heather S Lipkind; Henry C Lee; Haiqun Lin; Lisbet S Lundsberg; Xiao Xu
Journal:  Obstet Gynecol       Date:  2020-07       Impact factor: 7.623

10.  Cesarean section rates in Brazil: Trend analysis using the Robson classification system.

Authors:  Edson Luciano Rudey; Maria do Carmo Leal; Guilhermina Rego
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.